What is the current valuation of the South America oligonucleotide pool market?

As of 2024, the market valuation stands at 167.0 USD Million. Read More

What is the projected market size for the South America oligonucleotide pool market by 2035?

The market is expected to reach a valuation of 401.53 USD Million by 2035. Read More

What is the expected CAGR for the South America oligonucleotide pool market during the forecast period?

The market is projected to grow at a CAGR of 8.3% from 2025 to 2035. Read More

Which application segments are driving the South America oligonucleotide pool market?

Key application segments include Gene Synthesis, PCR Amplification, and Next Generation Sequencing, with valuations ranging from 30.0 to 100.0 USD Million. Read More

What are the primary end-use sectors for oligonucleotide pools in South America?

The primary end-use sectors include Pharmaceutical Companies and Diagnostic Laboratories, with valuations between 52.0 and 120.0 USD Million. Read More

What types of oligonucleotides are available in the South America market?

The market offers Custom Oligonucleotides, Pre-Designed Oligonucleotides, and Universal Oligonucleotides, with valuations from 47.0 to 150.0 USD Million. Read More

What technologies are utilized in the South America oligonucleotide pool market?

Technologies such as Solid Phase Synthesis and Liquid Phase Synthesis are utilized, with valuations ranging from 50.0 to 150.0 USD Million. Read More

How are oligonucleotide pools distributed in South America?

Distribution channels include Online Sales and Direct Sales, with valuations between 50.0 and 150.0 USD Million. Read More

Who are the key players in the South America oligonucleotide pool market?

Key players include Thermo Fisher Scientific, Integrated DNA Technologies, and Eurofins Genomics, among others. Read More

What trends are influencing the growth of the South America oligonucleotide pool market?

Trends such as increased demand for gene editing and advancements in sequencing technologies are likely influencing market growth. Read More

South America Oligonucleotide Pool Market

ID: MRFR/HC/55083-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

South America Oligonucleotide Pool Market Research Report By Type (DNA, RNA), By Application (Research, Diagnostic & Therapeutics, Others), By End User (Commercial Research, Pure Academic Research, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America Oligonucleotide Pool Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Gene Synthesis
  2. 4.1.2 Gene Editing
  3. 4.1.3 PCR Amplification
  4. 4.1.4 Next Generation Sequencing
  5. 4.1.5 Antisense Oligonucleotides
2. 4.2 Healthcare, BY End Use (USD Million)
  1. 4.2.1 Academic Research
  2. 4.2.2 Pharmaceutical Companies
  3. 4.2.3 Biotechnology Firms
  4. 4.2.4 Diagnostic Laboratories
3. 4.3 Healthcare, BY Type (USD Million)
  1. 4.3.1 Custom Oligonucleotides
  2. 4.3.2 Pre-Designed Oligonucleotides
  3. 4.3.3 Universal Oligonucleotides
4. 4.4 Healthcare, BY Technology (USD Million)
  1. 4.4.1 Solid Phase Synthesis
  2. 4.4.2 Liquid Phase Synthesis
  3. 4.4.3 Microarray Technology
5. 4.5 Healthcare, BY Distribution Channel (USD Million)
  1. 4.5.1 Online Sales
  2. 4.5.2 Direct Sales
  3. 4.5.3 Distributors
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Integrated DNA Technologies (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Eurofins Genomics (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bioneer Corporation (KR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 GenScript (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sigma-Aldrich (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bio-Rad Laboratories (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Agilent Technologies (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY END USE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY TYPE
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY TYPE, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  2. 7.2.2 BY END USE, 2026-2035 (USD Million)
  3. 7.2.3 BY TYPE, 2026-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
  5. 7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Healthcare Market Segmentation

Healthcare By Application (USD Million, 2022-2035)

Gene Synthesis
Gene Editing
PCR Amplification
Next Generation Sequencing
Antisense Oligonucleotides

Healthcare By End Use (USD Million, 2022-2035)

Academic Research
Pharmaceutical Companies
Biotechnology Firms
Diagnostic Laboratories

Healthcare By Type (USD Million, 2022-2035)

Custom Oligonucleotides
Pre-Designed Oligonucleotides
Universal Oligonucleotides

Healthcare By Technology (USD Million, 2022-2035)

Solid Phase Synthesis
Liquid Phase Synthesis
Microarray Technology

Healthcare By Distribution Channel (USD Million, 2022-2035)

Online Sales
Direct Sales
Distributors

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”